期刊文献+

半乳糖凝集素-3在人脑星形细胞瘤中的表达及其与预后的关系

Expression of Galectin-3 in Human Astrocytomas and Its Relationship with Prognosis
下载PDF
导出
摘要 目的探讨半乳糖凝集素-3﹙Gal-3﹚在星形细胞瘤不同病理分级中的生物学意义及其与预后的关系。方法应用免疫组化SP法检测46例首次手术切除的星形细胞瘤标本和8例正常脑组织标本中Gal-3的表达,并将它的表达与患者各临床指标之间进行统计学分析。结果正常脑组织中无明显Gal-3的表达,随着星形细胞瘤病理分级的提高,Gal-3的阳性表达逐渐升高(P<0.05),且其表达与肿瘤直径有关(P<0.05),其阳性表达的患者2年生存率低比阴性表达者低(P<0.01)。结论Gal-3在星形细胞瘤中的表达上调可能对肿瘤发生、发展和恶性转化具有重要的作用,对于肿瘤恶性程度分级、预后评估有一定的价值。 Objective To explore the expression of galectin-3 in the different pathological grades astrocytomas and its relationship ,with the prognosis. Methods The expressions of galectin-3 in 46 cases of human astrocytomas and 8 cases of normal brain tissues were determined by immmunohistochemical SP method. The relationship between the expression of galectin-3 in the human astrocytomas and the prognosis was analyzed. Results There is no expression of galectin-3 in 8 normal brain tissues, where the rate of positive expression of galectin-3 was significantly lower than that in the astrocytomas (P〈0.01). The positive expression rate of galectin- 3 was different statistically in different pathological grade. There was significant difference in the positive expression rate of galectin-3 among the astrocytomas of different grades (P〈0.05). The expression rate of galectin-3 was positively related to the diameter of the tumors (P〈0.05). The 2 years or more survival rate in patients with positive expression of galectin-3 was significantly lower than that of patients with negative expression (P〈0.01). Conclusions The over expression of galectin-3 may be involved in pathogensis and deve.lopment of astrocytomas. The detection of the level of galectin-3 is helpful to the prognostic assessment in the patients with astrocytomas.
出处 《中国临床神经外科杂志》 2007年第6期338-340,共3页 Chinese Journal of Clinical Neurosurgery
关键词 半乳糖凝集素-3 星形细胞瘤 病理分级 预后 Galectin-3 Astrocytomas Pathological grade Prognosis
  • 相关文献

参考文献10

  • 1Chen HY,Liu FT,Yang RY.Roles of galectin-3 in immune responses[J].Arch Immunol Ther Exp (Warsz),2005,53(6):497~504.
  • 2Califice S,Castronovo V,Van Den Brule F.Galectin-3 and cancer (Review)[J].Int J Oncol,2004,25(4):983~992.
  • 3Rabinovich G.Galectins:an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy[J].Cell Death Differ,1999,6:711~721.
  • 4Horwitz AR,Parsons JT.Cell migration-moving on[J].Science,1999,286:1102~1103.
  • 5van den Brule F,Califice S,Castronovo V.Expression of galectins in cancer:a critical review[J].Glycoconj J,2004,19(7-9):537~542.
  • 6Bresalier RS,Yan PS,Byrd JC,et al.Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system[J].Cancer,1997,80:776~787.
  • 7Debray C,Vereecken P,Belot N,et al.Multifaceted role of galectin-3 on human glioblastoma cell motility[J].Biochem Biophys Res Commun,2004,325:1393~1398.
  • 8Hidenori I,Shiro A,Avraham R.Galectin-3 Stimulates Cell Proliferation[J].Exper Cell Res,1998,245:294~302.
  • 9Nakahara S,Oka N,Raz A.On the role of galectin-3 in cancer apoptosis[J].Apoptosis,2005,10(2):267~275.
  • 10Grassadonia A,Tinari N,Iurisci I,et al.90K (Mac-2 BP)and galectins in tumor progression and metastasis[J].Glycoconj J,2004,19(7-9):551~612.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部